Warburg Pincus

Investment Thesis

Warburg Pincus invests in growth-oriented companies across sectors with a focus on identifying transformational opportunities. In healthcare, they seek companies with differentiated technologies, large addressable markets, and strong management teams. They provide patient capital and operational support to help companies scale globally.

Team

Partners / Managing Directors (Healthcare Focus)

• Chip Kaye - Co-CEO
• Jeff Perlman - Managing Director, Healthcare
• Chris Paull - Managing Director, Healthcare
• Frank Wei, MD - Managing Director, Healthcare

Other Key Team Members

• Ved Pandya - Managing Director
• Healthcare team across US, Europe, and Asia offices

Focus Areas

• Biotechnology
• Pharmaceuticals
• Healthcare Services
• Healthcare Technology
• Diagnostics
• Life Sciences Tools
• Genomics & Precision Medicine

Notable Portfolio Companies (Healthcare)

• Helix - Population genomics platform ($200M funding round, 2018)
• Modernizing Medicine - Healthcare IT
• WellSky - Healthcare software
• InVitae - Genetic testing
• Bausch Health - Pharmaceuticals

Notable Exits

• Bausch & Lomb - IPO and subsequent transactions
• Endogastric Solutions - Acquired
• Outset Medical - IPO (NASDAQ: OM)
• Alignment Healthcare - IPO (NASDAQ: ALHC)
• Multiple healthcare services exits through trade sales

Global Presence

• Offices in 14 countries
• Healthcare investments across US, Europe, Asia
• Dedicated China healthcare practice
• India healthcare investments through local teams

Sources

• Warburg Pincus website: https://www.warburgpincus.com
• https://www.warburgpincus.com/people
• SEC filings
• Crunchbase: https://www.crunchbase.com/organization/warburg-pincus